Stocks and Investing Stocks and Investing
Thu, January 20, 2022
[ 12:00 AM ] - WOPRAI
Edward Yruma Upgraded (VRM) to Buy on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
John Eade Downgraded (VOD) to Hold on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Keegan Carl Initiated (VICI) at Strong Buy and Held Target at $35 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Brooke Roach Maintained (VFC) at Strong Sell with Decreased Target to $68 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Sam Poser Downgraded (VFC) to Hold on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
David Konrad Downgraded (USB) to Hold and Decreased Target to $64 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (USB) at Hold with Decreased Target to $66 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Erika Najarian Maintained (USB) at Strong Buy with Decreased Target to $64 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Terry McEvoy Maintained (USB) at Hold with Decreased Target to $62 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Bill Carache Maintained (USB) at Buy with Decreased Target to $73 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Joshua Dennerlein Upgraded (WPC) to Hold on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Edward Yruma Downgraded (WMT) to Hold on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Vikram Malhotra Upgraded (WELL) to Strong Buy and Increased Target to $94 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Vikram Malhorta Initiated (SPG) at Hold and Held Target at $162 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Leo Mariani Maintained (SM) at Buy with Increased Target to $44 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Shahriar Pourreza Downgraded (SR) to Hold and Held Target at $71 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Neel Kumar Maintained (CCK) at Buy with Increased Target to $135 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Derrick Wood Maintained (TEAM) at Hold with Decreased Target to $325 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Edward Yruma Maintained (TDUP) at Buy with Decreased Target to $18 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Samik Chatterjee Maintained (TEL) at Buy and Held Target at $176 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Elyse Greenspan Maintained (TRV) at Hold and Held Target at $161 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Jimmy Bhullar Maintained (TRV) at Sell and Held Target at $165 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
John Lovallo Initiated (TREX) at Hold and Held Target at $111 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Theresa Chen Maintained (TRGP) at Buy with Increased Target to $72 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
Yiwen Zhang Downgraded (TME) to Hold on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
John Ransom Upgraded (THC) to Strong Buy and Increased Target to $120 on, Jan 20th, 2022
[ 12:00 AM ] - WOPRAI
John Lovallo Initiated (TOL) at Hold and Held Target at $71 on, Jan 20th, 2022
Wed, January 19, 2022
[ 12:00 AM ] - WOPRAI
Richard Shane Maintained (AXP) at Buy with Decreased Target to $198 on, Jan 19th, 2022
[ 12:00 AM ] - WOPRAI
Kenneth Zener Downgraded (TOL) to Sell and Held Target at $56 on, Jan 19th, 2022
[ 12:00 AM ] - WOPRAI
Lawrence Biegelsen Upgraded (TNDM) to Buy and Held Target at $160 on, Jan 19th, 2022

Lawrence Biegelsen Upgraded (TNDM) to Buy and Held Target at $160 on, Jan 19th, 2022


Published on 2024-10-27 19:20:47 - WOPRAI, Lawrence Biegelsen
  Print publication without navigation


Lawrence Biegelsen of Wells Fargo, Upgraded "Tandem Diabetes Care, Inc." (TNDM) to Buy and Held Target at $160 on, Jan 19th, 2022.

Lawrence has made no other calls on TNDM in the last 4 months.



There are 2 other peers that have a rating on TNDM. Out of the 2 peers that are also analyzing TNDM, 1 agrees with Lawrence's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $140 on, Thursday, November 4th, 2021


This is the rating of the analyst that currently disagrees with Lawrence

  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $138 on, Thursday, November 4th, 2021
Contributing Sources